{
  "meta": {
    "title": "276_Obstetrics_And_Gynecology_Neet_2019",
    "url": "https://brainandscalpel.vercel.app/276-obstetrics-and-gynecology-neet-2019-065470c5.html",
    "scrapedAt": "2025-11-30T12:57:44.297Z"
  },
  "questions": [
    {
      "text": "In which trimester does acute fatty liver manifest most commonly during pregnancy?",
      "choices": [
        {
          "id": 1,
          "text": "First trimester"
        },
        {
          "id": 2,
          "text": "Second trimester"
        },
        {
          "id": 3,
          "text": "Third trimester"
        },
        {
          "id": 4,
          "text": "Both (a) and (b)"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Acute fatty live</strong>r of pregnancy (AFLP) occurs most commonly in the&nbsp;<strong>third&nbsp;trimester</strong>&nbsp;or early postpartum period.</p>\n<p>Risk factors include <strong>Pre-eclampsia/HELLP</strong> syndrome, <strong>male</strong> fetus, <strong>previous</strong> history of <strong>AFLP,</strong> and <strong>multiple</strong> gestations.</p>\n<p><strong>AFLP</strong> (acute yellow atrophy or acute fatty metamorphosis) is the most common cause of <strong>acute liver failure</strong> in pregnancy. It usually occurs in the&nbsp;<strong>later stages of pregnancy,&nbsp;</strong>particularly in the&nbsp;<strong>third</strong>&nbsp;trimester.&nbsp;It occurs due to&nbsp;<strong>fetal deficiency&nbsp;</strong>of<strong>&nbsp;long-chain acyl-coenzyme A dehydrogenase</strong>&nbsp;(LCHAD) or poor placental mitochondrial function.</p>\n<p>The patients present with persistent nausea and&nbsp;vomiting,&nbsp;<strong>progressive&nbsp;jaundice</strong>, and epigastric pain. Features like acute hemolysis,&nbsp;<strong>hypoglycemia</strong>, hypertension, proteinuria, thrombocytopenia, and edema can also be present. Symptoms may progress to<strong> fulminant hepatic failure</strong> with encephalopathy, <strong>disseminated intravascular coagulation</strong>, and death.</p>\n<p>Liver function tests such as <strong>AST, ALT</strong>, and serum bilirubin levels are <strong>raised</strong>. <strong>Hypofibrinogenemia</strong>, <strong>hypocholesterolemia</strong>, and <strong>prolonged clotting time</strong> can be seen. An <strong>elevated d-dimer</strong> is seen.&nbsp;Microscopy reveals a characteristic<strong>&nbsp;microvesicular fatty infiltration</strong>.</p>\n<p>The condition worsens till delivery after which the hepatic dysfunction resolves. A <strong>trial of labor</strong> by induction or delivery by<strong> Cesarean</strong> is done. Intensive <strong>supportive measures</strong> including blood transfusion should be provided.</p>\n<div class=\"page\" title=\"Page 281\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 281\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The clinical and laboratory findings of acute liver diseases in pregnancy are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorders&nbsp;</strong></td>\n<td><strong>HELLP syndrome</strong></td>\n<td><strong>Obstetric cholestasis</strong></td>\n<td><strong>Acute fatty liver of pregnancy</strong></td>\n<td><strong>Viral hepatitis</strong></td>\n</tr>\n<tr>\n<td><strong>Onset in pregnancy</strong></td>\n<td>Mid to late</td>\n<td>Late</td>\n<td>Late</td>\n<td>Variable</td>\n</tr>\n<tr>\n<td><strong>Differentiating features&nbsp;</strong></td>\n<td>\n<p><strong>Epigastric pain</strong>, hypertension,</p>\n<p>elevated <strong>indirect bilirubin&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Pruritus&nbsp;</strong>&nbsp;</p>\n<p>elevated <strong>direct bilirubin</strong></p>\n</td>\n<td>Signs of<strong> liver failure</strong>&nbsp;like <strong>hypoglycemia</strong></td>\n<td><strong>Fever</strong></td>\n</tr>\n<tr>\n<td><strong>AST (U/L)</strong></td>\n<td>&nbsp;&le;300</td>\n<td>&nbsp;&le;200</td>\n<td><strong>200-800</strong></td>\n<td><strong>2000+</strong></td>\n</tr>\n<tr>\n<td><strong>Bilirubin (mg/dL)</strong></td>\n<td>1-4</td>\n<td>1-5</td>\n<td><strong>4-10</strong></td>\n<td><strong>5-20</strong></td>\n</tr>\n<tr>\n<td><strong>Platelets</strong></td>\n<td>&darr;&darr;&nbsp;</td>\n<td><strong>Normal</strong></td>\n<td>&darr;&darr;&nbsp;</td>\n<td>&darr;</td>\n</tr>\n<tr>\n<td><strong>Fibrinogen</strong></td>\n<td><strong>Normal</strong></td>\n<td><strong>Normal</strong></td>\n<td><strong>&darr;&darr;&darr;&nbsp;</strong></td>\n<td><strong>Normal</strong></td>\n</tr>\n<tr>\n<td><strong>D-dimer</strong></td>\n<td>&uarr;</td>\n<td><strong>Normal</strong></td>\n<td><strong>&uarr;</strong></td>\n<td><strong>Normal</strong></td>\n</tr>\n<tr>\n<td><strong>Prothrombin time</strong></td>\n<td><strong>Normal</strong></td>\n<td><strong>Normal</strong></td>\n<td><strong>&uarr;</strong><strong>&uarr;</strong></td>\n<td>&nbsp;&uarr;</td>\n</tr>\n<tr>\n<td><strong>Hemolysis</strong></td>\n<td>&nbsp;&uarr;&uarr;</td>\n<td><strong>No</strong></td>\n<td>&uarr;&uarr;&uarr;</td>\n<td>&nbsp;<strong>No</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The condition <strong>worsens</strong> till delivery after which the hepatic dysfunction resolves. Appropriate management is immediate termination of pregnancy irrespective of gestational age by induction or delivery by Cesarean (for obstetric reasons) is done. Intensive supportive measures including blood transfusion should be provided.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4283",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true about vaginal changes in a normal pregnancy?",
      "choices": [
        {
          "id": 1,
          "text": "Decreased number of Lactobacilli"
        },
        {
          "id": 2,
          "text": "Increased glycogen metabolism in the epithelium"
        },
        {
          "id": 3,
          "text": "pH > 6.8"
        },
        {
          "id": 4,
          "text": "Epithelial thinning"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>There is an <strong>increase</strong> in the <strong>metabolism</strong> of <strong>glycogen&nbsp;</strong>in the vaginal epithelium during normal pregnancy.</p>\n<p>The changes in the vagina during pregnancy include:</p>\n<ul>\n<li><strong>Increased vascularity</strong> and hyperemia resulting in a violet/purplish color characteristic of <strong>Chadwick's sign</strong></li>\n<li><strong>Vaginal epithelium</strong> undergoes <strong>marked proliferation </strong>(option D) with the extension of the squamocolumnar junction downwards</li>\n<li><strong>Vaginal pH decreases </strong>and&nbsp;becomes more&nbsp;<strong>acidic </strong>(option C)&nbsp;and varies from 3.5-6.0.</li>\n<li><strong>Increase</strong> in the number of <em><strong>Lactobacillus acidophilus </strong></em>(option A)<em>.</em>&nbsp;It metabolizes the glycogen stores and causes an increased production of lactic acid. Therefore, the pH becomes acidic.</li>\n<li><strong>Increased</strong> volume of <strong>cervical secretion</strong>&nbsp;during pregnancy results in the production of&nbsp;<strong>thick white vaginal discharge</strong>.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5126",
      "difficulty": "medium"
    },
    {
      "text": "You discover that there is evidence of cardiac malformation in a fetus during a routine USG scan at 16 weeks. What is the minimum level of fasting blood sugar at which you can suspect overt diabetes?",
      "choices": [
        {
          "id": 1,
          "text": "106 mg/dL"
        },
        {
          "id": 2,
          "text": "126 mg/dL"
        },
        {
          "id": 3,
          "text": "116 mg/dL"
        },
        {
          "id": 4,
          "text": "130 mg/dL"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Overt diabetes </strong>is when&nbsp;<strong>fasting blood sugar</strong> is <strong>&ge; 126 mg/dl</strong>. Overt diabetics are women who are known to have <strong>diabetes before pregnancy</strong>.&nbsp;</p>\n<p>A patient is said to have overt diabetes if:</p>\n<ul>\n<li>Fasting blood sugar &ge; 126 mg/dL</li>\n<li>A random blood sugar of &ge; 200 mg/dL</li>\n<li>HbA1c of &ge; 6.5%</li>\n</ul>\n<p><strong>The maternal complication of diabetes:</strong></p>\n<ul>\n<li>increased Miscarriage and preterm labor.</li>\n<li>increased incidence of preeclampsia</li>\n<li>polyhydramnios</li>\n<li>prolongation of labor due to shoulder dystocia, operative interference, and cephalo-pelvic disproportion.</li>\n</ul>\n<p><strong>Fetal and Neonatal complications of diabetes:</strong></p>\n<ul>\n<li>fetal macrosomia (birth weight &gt; 4kg)</li>\n<li>congenital malformations - Musculoskeletal, urogenital, and CNS anomalies.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1753",
      "difficulty": "easy"
    },
    {
      "text": "A 45-year-old woman presented with a lower abdominal mass and lower abdominal discomfort. On examination, the uterus appears uniformly enlarged and adnexa is free. MRI shows the presence of a myometrial cyst. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Endometriosis"
        },
        {
          "id": 2,
          "text": "Adenomyosis"
        },
        {
          "id": 3,
          "text": "Leiomyoma"
        },
        {
          "id": 4,
          "text": "Endometrial hyperplasia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Multiparous women &gt;40yrs, presenting with abdominal mass (free from adnexa) and myometrial cysts on MRI, point towards a diagnosis of adenomyosis.</p>\n<p><strong>Adenomyosis</strong>&nbsp;refers to the growth of the&nbsp;<strong>endometrium</strong>&nbsp;(both stromal and glandular components) directly into the&nbsp;<strong>myometrium</strong>. It is predominantly seen in&nbsp;<strong>multiparous women&nbsp;</strong>above the age of&nbsp;<strong>40 years</strong>. Patients generally present with&nbsp;<strong>menorrhagia</strong>,&nbsp;<strong>dysmenorrhea</strong>, and sometimes dyspareunia. On examination, there is a&nbsp;<strong>gross symmetrical enlargement</strong>&nbsp;of the&nbsp;<strong>uterus</strong>&nbsp;corresponding to&nbsp;<strong>12-14 weeks size</strong>. The uterus is&nbsp;<strong>soft</strong>&nbsp;and&nbsp;<strong>tender</strong> on bimanual examination.&nbsp;</p>\n<p>Transvaginal ultrasonography (<strong>TVS</strong>) reveals a<strong> salt-and-pepper appearance&nbsp;</strong>of the myometrium and the presence of <strong>sub-endometrial striations</strong>&nbsp;producing&nbsp;the&nbsp;<strong>Venetian blind</strong> appearance. MRI can also be done for diagnosis. However, the only<strong>&nbsp;definitive&nbsp;</strong>mode of<strong>&nbsp;diagnosis&nbsp;</strong>is<strong>&nbsp;histopathological examination.</strong></p>\n<p>Since most women affected by the condition are past the childbearing age,&nbsp;<strong>total hysterectomy</strong>&nbsp;is the&nbsp;<strong>treatment of choice.&nbsp;</strong>Localized excision/Levonorgestrel containing IUCD can be tried in younger women.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/da7b46b87be54db48f61e592ed9794b7x1280x1362.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: <strong>Endometriosis</strong> refers to the presence of <strong>endometrial tissue outside the endometrial lining</strong> (uterus). They usually present as dysmenorrhea and lower dull abdominal pain. Vaginal examination reveals a<strong> tender fixed retroverted uterus</strong>. They can be managed medically (oral contraceptives, aromatase inhibitors, etc)&nbsp; and surgically (if failed medical management). Abdominal hysterectomy with bilateral salpingo-oophorectomy is performed in advanced cases.</p>\n<p>Option C: <strong>Leiomyoma </strong>(fibroid) is the commonest benign tumor arising from the uterus. They present as abnormal uterine bleeding, <strong>infertility</strong>, and abdominal pain. On bimanual examination, the <strong>uterus</strong> is<strong> enlarged </strong>and the<strong> mass moves with the cervix</strong>. It can be managed medically (mifepristone or newer progesterone) and surgically. A myomectomy is performed for large fibroids with significant symptoms.</p>\n<p>Option D: <strong>Endometrial hyperplasia</strong> can be simple, glandular, or atypical. They are seen in women with estrogen excess states like obesity, PCOD, or on tamoxifen therapy. They usually present as abnormal uterine bleeding <strong>(AUB)</strong>.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6420",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following decreases in pregnancy?",
      "choices": [
        {
          "id": 1,
          "text": "Respiratory rate"
        },
        {
          "id": 2,
          "text": "Vital capacity"
        },
        {
          "id": 3,
          "text": "Functional residual capacity"
        },
        {
          "id": 4,
          "text": "Inspiratory capacity"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Functional residual capacity</strong>&nbsp;decreases in pregnancy.</p>\n<p>The <strong>changes in the respiratory system</strong> during pregnancy are:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Increase</strong></p>\n</td>\n<td>\n<p><strong>Decrease</strong></p>\n</td>\n<td>\n<p><strong>Unaffected</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Tidal volume</li>\n<li>Inspiratory capacity</li>\n<li>Minute O<sub>2</sub> uptake</li>\n<li>Minute ventilation</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Functional residual capacity</li>\n<li>Expiratory reserve volume</li>\n<li>Residual volume</li>\n<li>Total lung capacity</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Respiratory rate</li>\n<li>Vital capacity</li>\n<li>Inspiratory reserve volume&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>(Mnemonic: <strong>TIMM</strong> increases in pregnancy)</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9755",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a contraindication for the induction of labor?",
      "choices": [
        {
          "id": 1,
          "text": "Pelvic tumor"
        },
        {
          "id": 2,
          "text": "Herpes infection"
        },
        {
          "id": 3,
          "text": "Heart disease"
        },
        {
          "id": 4,
          "text": "History of lower transverse cesarean section in last three pregnancies"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Heart disease </strong>is currently not considered a contraindication for the induction of labor. <strong>Vaginal delivery</strong> is <strong>preferred&nbsp;</strong>in such patients.</p><hr><h3>Related Pearl: Indications & contraindications for induction of labor</h3><div class=\"p-rich_text_section\"><strong data-stringify-type=\"bold\">Indications</strong>:</div>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet\" data-stringify-type=\"unordered-list\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Uncontrolled maternal diabetes mellitus</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Gestational hypertension</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Pre-eclampsia</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Post-term pregnancy</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Abruption placentae</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Premature rupture of membranes</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Rh-isoimmunization</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Intra-uterine growth restriction (IUGR)</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Intra-uterine death (IUD)</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Oligohydramnios</li>\n</ul>\n<div class=\"p-rich_text_section\"><strong data-stringify-type=\"bold\">Contraindications</strong>:</div>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet\" data-stringify-type=\"unordered-list\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Contracted/distorted pelvis and cephalopelvic disproportion</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Placenta previa or vasa previa</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Active genital herpes</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Pelvic tumor &amp; carcinoma cervix</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Transverse lie or footling breech</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Appreciable macrosomia</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Severe hydrocephalus</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Umbilical cord prolapse</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">High-risk pregnancy with fetal compromise</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Previous classical cesarean or hysterotomy</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Previous history of uterine rupture</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Pelvic surgeries like vesicovaginal fistula/rectovaginal fistula/pelvic floor repair (third or fourth-degree perineal tears repair)</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Previous 3 or more lower transverse cesarian sections.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5425",
      "difficulty": "medium"
    },
    {
      "text": "The given image shows what grade of placenta previa?",
      "choices": [
        {
          "id": 1,
          "text": "IV"
        },
        {
          "id": 2,
          "text": "III"
        },
        {
          "id": 3,
          "text": "II"
        },
        {
          "id": 4,
          "text": "I"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows <strong>grade III placenta previa.&nbsp;</strong></p>\n<p>Placenta previa refers to the placenta<strong> implanted</strong> (partially/completely) over <strong>the lower uterine segment</strong> (over or adjacent to the internal os). Grades of placenta previa are:</p>\n<ul>\n<li>&nbsp;<strong>Type&mdash;I (Low-lying):</strong> The major part of the placenta is attached to the upper segment and only the<br />lower margin encroaches onto the lower segment but not up to the os.</li>\n<li><strong>Type&mdash;II (Marginal):</strong> The placenta reaches the margin of the internal os but does not cover it.</li>\n<li><strong>Type&mdash;III (Incomplete or partial central):</strong> The placenta covers the internal os <strong>partially</strong> (covers the<br />internal os when closed but does not entirely do so when fully dilated).</li>\n<li><strong>Type&mdash;IV (Central or total):</strong> The placenta completely covers the internal os <strong>even after it is fully dilated</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5111bcfe81ba4d80842ad5fce06520d0x1280x2004.JPEG\" alt=\"Explanation Image\"><p>They typically present with <strong>sudden onset, painless vaginal bleeding</strong>. On vulval inspection,<strong> bright red blood</strong> is seen oozing from the <strong>cervical opening</strong>. Transvaginal ultrasound (<strong>TVS</strong>) is used to confirm the <strong>diagnosis and position of the placenta</strong>.</p>\n<p>Management is dependent on the presentation of the patient. If there is a <strong>need for fetal maturity</strong>, expectant management (advocated by <strong>McAfee and Johnson</strong>) is carried out without increasing undue maternal stress. <strong>Definitive management</strong> by an elective<strong> cesarean section</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/629f83b53d1045f69066b9118f810988.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7187",
      "difficulty": "medium"
    },
    {
      "text": "All are normal physiological changes in pregnancy except:",
      "choices": [
        {
          "id": 1,
          "text": "Left axis deviation"
        },
        {
          "id": 2,
          "text": "Mild ST changes in inferior leads"
        },
        {
          "id": 3,
          "text": "Atrial and ventricular premature contractions"
        },
        {
          "id": 4,
          "text": "Pansystolic murmur"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Physiological changes in pregnancy</strong></p>\n<p><strong>Clinical examination</strong></p>\n<ul>\n<li>Jugular venous distension and venous hum</li>\n<li>Mammary souffl&eacute;: Continuous murmur at 2<sup>nd</sup> to 4<sup>th</sup> intercostal space</li>\n<li>Occassional S3at Mitral area</li>\n<li>Aortic or pulmonary flow murmurs at aortic/pulmonary areas</li>\n<li>S2 P increased; S2 split</li>\n<li>S1 M increased and widely split</li>\n</ul>\n<p><strong>Electrocardiography</strong></p>\n<ul>\n<li>T wave inversion, biatrial enlargement</li>\n<li>Dysrhythmias</li>\n<li>As the diaphragm is elevated in advancing pregnancy, there is an average <strong>15-degree left-axis deviation</strong> in the electrocardiogram (ECG), and mild ST changes may be seen in the inferior leads.</li>\n<li>Atrial and ventricular premature contractions are relatively frequent</li>\n<li>Pregnancy does not alter voltage</li>\n<li>Tricuspid regurgitation</li>\n<li>Increased left atrial end-diastolic dimension and</li>\n<li>Increased left ventricular mass</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1989",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant woman with a fibroid uterus develops severe acute pain abdomen at 28 weeks of gestation. There is no history of fever and the WBC count is 8000 cells/mL.  The most likely diagnosis is:",
      "choices": [
        {
          "id": 1,
          "text": "Red degeneration of fibroid"
        },
        {
          "id": 2,
          "text": "Preterm labour"
        },
        {
          "id": 3,
          "text": "Torsion of fibroid"
        },
        {
          "id": 4,
          "text": "None of the above"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario of <strong>severe acute abdominal pain</strong> <strong>without fever/leucocytosis</strong> in a pregnant woman with a fibroid is suggestive of <strong>fibroid torsion.</strong></p>\n<p>The incidence of fibroid in pregnancy is about 1 in 1,000. Due to increased vascularity in pregnancy, the fibroid increases in size and becomes softer. <strong>The torsion</strong> is seen in the <strong>subserous pedunculated fibroid</strong> where the venous return is blocked at its site of attachment in the uterus. This leads to severe acute abdominal pain. Due to the complication being more local than systemic, <strong>fever or leucocytosis </strong>are generally<strong> not seen</strong>.</p>\n<p>A transvaginal ultrasonogram is immediately done to detect the position and size of the fibroid, which is followed by <strong>laparotomic</strong> <strong>myomectomy</strong> as a part of emergency surgical management.&nbsp;</p>\n<p>Other options:</p>\n<p>Option A: <strong>Red degeneration of fibroid</strong> is seen commonly in the <strong>second</strong> <strong>half</strong> of pregnancy or puerperium. It is due to a <strong>hemorrhagic</strong> <strong>infarction</strong> of the tissue and typically presents as <strong>acute</strong> <strong>focal</strong> <strong>abdominal</strong> <strong>pain</strong> with <strong>fever</strong> and <strong>leucocytosis</strong>. Treatment is usually conservative with bed rest, analgesics, and sedatives.</p>\n<p>Option B: <strong>Preterm</strong> <strong>labor</strong> is where the labor starts before 37 completed weeks. It is characterized by true labor pain. The abdominal pain is <strong>slowly increasing in intensity and duration</strong> and is also accompanied by <strong>show</strong> (expulsion of the cervical mucus plug). There are <strong>intervals</strong> between <strong>episodes</strong> of contractions where the patient <strong>doesn't complain of abdominal pain</strong>.</p><hr><h3>Related Pearl: Secondary changes and complications in fibromyomas</h3><div class=\"page\" title=\"Page 408\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Hyaline change, cystic degeneration and atrophy</li>\n<li>Calcareous degeneration, osseous degeneration</li>\n<li>Red degeneration</li>\n<li>Sarcomatous change</li>\n<li>Torsion, hemorrhage</li>\n<li>Infection/ ulceration, particularly in the dependent part of a submucous polyp</li>\n<li>Inversion of the uterus</li>\n<li>Endometrial carcinoma associated with fibromyoma</li>\n<li>Endometrial and myohyperplasia</li>\n<li>Accompanying adenomyosis</li>\n<li>Parasitic fibroid</li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7509",
      "difficulty": "medium"
    },
    {
      "text": "What is the first line of treatment of mastitis in a lactating mother?",
      "choices": [
        {
          "id": 1,
          "text": "Dicloxacillin"
        },
        {
          "id": 2,
          "text": "Cefazolin"
        },
        {
          "id": 3,
          "text": "Ceftriaxone"
        },
        {
          "id": 4,
          "text": "Ampicillin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Dicloxacillin</strong> is the first line of treatment for <strong>mastitis</strong> in lactating mothers and should be taken for 10-14 days.</p>\n<p><strong>Mastitis</strong> refers to the infection of the breast parenchymal tissue. The most common organism causing breast infection is <em>Staphylococcus aureus</em>.&nbsp;It is common in new mothers at the&nbsp;<strong>beginning of lactation</strong>&nbsp;who are inexperienced with breastfeeding or&nbsp;<strong>during weaning</strong>&nbsp;when nipple trauma occurs due to the infant's growing teeth.&nbsp;</p>\n<p>Clinical features of mastitis include:</p>\n<ul>\n<li aria-level=\"1\">Fever and malaise</li>\n<li aria-level=\"1\">Localized pain and tenderness&nbsp;</li>\n<li aria-level=\"1\">Purulent nipple discharge</li>\n<li aria-level=\"1\">Redness and swelling of the affected breast</li>\n<li aria-level=\"1\">Positive fluctuation test</li>\n</ul>\n<p>A culture from nipple discharge or test-needle aspiration of the cellulitic area is done to confirm the organism and its antibiotic sensitivity. An ultrasonogram of the involved breast is done to exclude abscess. They are treated with antibiotics and adequate breast support.&nbsp;Choice of antibiotics in lactational mastitis:</p>\n<ol>\n<li><strong>Dicloxacillin </strong>500 mg 4 times a day is to be started empirically.</li>\n<li><strong>Erythromycin</strong> is given to women who are <strong>penicillin-sensitive</strong>.</li>\n<li>If the infection is caused by resistant, penicillinase-producing Staphylococcus species then vancomycin, clindamycin, or trimethoprim-sulfamethoxazole is given for at least 10 days.</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7514",
      "difficulty": "medium"
    },
    {
      "text": "Major contributor for amniotic fluid post 20 weeks is?",
      "choices": [
        {
          "id": 1,
          "text": "Fetal urine"
        },
        {
          "id": 2,
          "text": "Fetal skin"
        },
        {
          "id": 3,
          "text": "Fetal lung fluid"
        },
        {
          "id": 4,
          "text": "Maternal plasma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Fetal urine </strong>is the major contributor to amniotic fluid <strong>post 20 weeks.</strong></p>\n<p><strong>Amniotic fluid&nbsp;</strong>is present in the amniotic cavity which is the space between the epiblast (ectoderm) and trophoblast. The volume of the amniotic fluid increases with pregnancy and reaches a maximum at term. It is contributed by:</p>\n<ul>\n<li>Early pregnancy -&nbsp;<strong>ultrafiltrate</strong>&nbsp;of&nbsp;<strong>maternal plasma</strong> (option D).&nbsp;</li>\n<li>Second trimester - the&nbsp;<strong>extracellular fluid</strong> that diffuses through the fetal skin (option B) and thus reflects the composition of <strong>fetal plasma.</strong></li>\n<li>After 20 weeks&nbsp;<strong>-</strong>&nbsp;keratinization of fetal skin prevents diffusion across the skin. Hence,&nbsp;<strong>fetal urine</strong>&nbsp;forms amniotic fluid.</li>\n</ul>\n<p>Note: Fetal kidneys start producing urine at&nbsp;<strong>12 weeks</strong> (8&ndash;11 weeks), and by 18 weeks, they produce 7 to 14 mL per day.</p><hr><h3>Related Pearl: Change in the amniotic fluid volume through gestation</h3><table>\n<tbody>\n<tr>\n<td><strong>Period of gestation </strong> &nbsp;</td>\n<td><strong>Amniotic fluid volume </strong></td>\n</tr>\n<tr>\n<td>10 weeks</td>\n<td>10-20 mL</td>\n</tr>\n<tr>\n<td>16 weeks</td>\n<td>250 mL</td>\n</tr>\n<tr>\n<td>33 weeks</td>\n<td>800 mL</td>\n</tr>\n<tr>\n<td>38-39 weeks</td>\n<td>plateaus at 1000 mL</td>\n</tr>\n<tr>\n<td>40 weeks</td>\n<td>&nbsp;800</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: The average volume increases with gestational age, peaking at <strong>800-1000 mL</strong>, which coincides with <strong>36-37</strong> weeks' gestation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7528",
      "difficulty": "easy"
    },
    {
      "text": "What will be the level of the anti-Mullerian hormone in low ovarian reserve?",
      "choices": [
        {
          "id": 1,
          "text": "<1"
        },
        {
          "id": 2,
          "text": "1-4"
        },
        {
          "id": 3,
          "text": ">7"
        },
        {
          "id": 4,
          "text": ">10"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In<strong> low ovarian reserve,</strong> the level of<strong> anti-Mullerian hormone</strong> (AMH)<strong> </strong>will be<strong> &lt;1 ng/ml. </strong></p>\n<p><strong>AMH</strong> is a glycoprotein secreted by the granulosa cells of the primordial follicle of the ovary. It helps in oocyte maturation and mono-follicular development. AMH is also used in assessing ovarian reserve.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>AMH levels in ng/ml</strong></td>\n<td><strong>Interpretation</strong></td>\n</tr>\n<tr>\n<td>2–6.8</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>&lt;1</td>\n<td>Poor ovarian reserve</td>\n</tr>\n<tr>\n<td>&gt;10</td>\n<td>\n<p>PCOD</p>\n<p>Hyperstimulation syndrome</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>In<strong> women</strong>, AMH is always absent during embryogenesis and is <strong>secreted by</strong> the <strong>granulosa cells</strong> after puberty. It helps in follicular development and oocyte maturation. <strong>Estimation of</strong> serum AMH is used in the study of<strong> ovarian reserve</strong> in female infertility and secondary amenorrhoea.</p>\n<p>In <strong>men</strong>, AMH starts to be <strong>secreted by</strong> the<strong> Sertoli cells</strong> in the testes by the 7th week of intrauterine life. It continues until puberty. It inhibits the development of the Müllerian system. The <strong>absence</strong> of AMH results in the development of <strong>hermaphroditism</strong>. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7530",
      "difficulty": "medium"
    },
    {
      "text": "The maximum dose of PGF2 alpha in postpartum hemorrhage is ____.",
      "choices": [
        {
          "id": 1,
          "text": "0.25 mg"
        },
        {
          "id": 2,
          "text": "2 mg"
        },
        {
          "id": 3,
          "text": "20 mg"
        },
        {
          "id": 4,
          "text": "200 mg"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong> maximum&nbsp;</strong>dose of <strong>prostaglandin F2 alpha&nbsp;</strong>in postpartum hemorrhage is <strong>2 mg.</strong></p>\n<p><strong>Prostaglandins&nbsp;</strong>are paracrine/autocrine hormones and act locally at the site of production. Main sources for:</p>\n<ol>\n<li>PGF<sub>2&alpha;&nbsp;</sub> - Decidua and promotes myometrial contractility</li>\n<li>PGE<sub>2</sub> - fetal membranes (amnion) and induces labor and promotes cervical effacement and dilatation</li>\n<li>PGI<sub>2</sub> - Myometrium&nbsp;</li>\n</ol>\n<p><strong>Carboprost</strong> tromethamine (hemabate) is the 15-methyl derivative of prostaglandin F2 alpha. It is approved for the treatment of&nbsp;<strong>uterine atony</strong> at a dose of <strong>0.25 mg</strong>&nbsp;<strong>IM.</strong>&nbsp;This dose can be repeated if necessary at 15- to 90-minute intervals up to a <strong>maximum</strong> of<strong> eight doses (2</strong> <strong>mg</strong>).</p>\n<p>It is the best drug to control PPH.&nbsp;ls also used an abortifacient in the second trimester.</p>\n<p><strong>Contraindications</strong> include<strong>&nbsp;asthmatic</strong> women and those with suspected <strong>amniotic fluid embolism</strong>, as they cause&nbsp;pulmonary&nbsp;airway and&nbsp;vascular constriction.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7533",
      "difficulty": "medium"
    },
    {
      "text": "Gestational trophoblastic neoplasm does not include",
      "choices": [
        {
          "id": 1,
          "text": "Partial mole"
        },
        {
          "id": 2,
          "text": "Choriocarcinoma"
        },
        {
          "id": 3,
          "text": "Placental site trophoblastic tumor"
        },
        {
          "id": 4,
          "text": "Invasive mole"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>A partial mole</strong> is <strong>not</strong> a gestational trophoblastic neoplasm (<strong>GTN</strong>).</p>\n<p>Gestational trophoblastic disease (<strong>GTD</strong>) is the term used to describe a group of tumors due to <strong>abnormal trophoblast proliferation</strong>. <strong>Malignant</strong> forms of GTD are termed gestational trophoblastic neoplasia (<strong>GTN</strong>).</p>\n<p>Modified WHO Classification of GTD</p>\n<table>\n<tbody>\n<tr>\n<td>Molar Pregnancies</td>\n<td>Trophoblastic tumors</td>\n</tr>\n<tr>\n<td>\n<p>Hydatidiform mole (<strong>benign</strong>) -<strong>Partial</strong> and <strong>Complete</strong><br />Invasive mole (malignant)</p>\n</td>\n<td>\n<p>Choriocarcinoma (malignant)<br />Placental site trophoblastic tumor (malignant)</p>\n<p>Epithelioid trophoblastic tumor (malignant)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7481",
      "difficulty": "easy"
    },
    {
      "text": "A baby was born at 34 weeks of pregnancy, the appearance of the baby is given below. What is the   mother suffering from ?",
      "choices": [
        {
          "id": 1,
          "text": "Gestational diabetes"
        },
        {
          "id": 2,
          "text": "Rubella"
        },
        {
          "id": 3,
          "text": "Hypothyroidism"
        },
        {
          "id": 4,
          "text": "Gestational hypertension"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image provided depicts a baby with <strong>macrosomia </strong>(large for gestational age), the most probable cause of which is <strong>gestational diabetes </strong>(GDM) in the mother.</p>\n<p>GDM in a mother is defined as <strong>carbohydrate</strong> <strong>intolerance</strong> with <strong>onset/first recognition</strong> during the <strong>present pregnancy</strong>. Diabetes in Pregnancy Societies of India (<strong>DIPSI</strong>) criteria is used to <strong>diagnose</strong> <strong>GDM</strong> (Venous plasma <strong>&gt;140mg %</strong> after <strong>2h</strong> of ingestion of <strong>75g</strong> of glucose).&nbsp;</p>\n<p><strong>Maternal </strong>Complications of GDM<strong>:</strong></p>\n<div class=\"page\" title=\"Page 351\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<ol>\n<li>During pregnancy - <strong>Recurrent</strong> <strong>spontaneous</strong> <strong>abortion</strong>, preterm labor, urinary tract infection,&nbsp;<strong>polyhydramnios</strong>, and increased incidence of preeclampsia</li>\n<li><span>During labor: <strong>Prolongation</strong> <strong>of labor</strong> (shoulder dystocia) and postpartum hemorrhage&nbsp;</span></li>\n</ol>\n<div class=\"page\" title=\"Page 351\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\"><span><strong>Neonatal</strong> complications -</span></div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<ol>\n<li><strong>Electrolyte imbalances - </strong>hypoglycemia, <strong>hypocalcemia</strong>, hypokalemia, hypomagnesemia</li>\n<li><strong>Respiratory </strong>system<strong> - </strong>respiratory distress syndrome and delayed lung maturity</li>\n<li><strong>Hematological </strong>system<strong> -</strong> polycythemia and <strong>single</strong> <strong>umbilical</strong> <strong>artery</strong></li>\n<li><strong>Renal </strong><span>system</span><strong> - </strong><span>hydronephrosis (<strong>renal</strong> <strong>agenesis</strong>) and polycystic kidneys</span></li>\n<li><span><strong>Cardiovascular</strong> system - VSD, ASD, Coarctation of the aorta, and TGA</span></li>\n<li><span><strong>Gastrointestinal</strong> system - duodenal atresia, tracheoesophageal fistula (<strong>TEF</strong>), and <strong>necrotizing</strong> <strong>enterocolitis</strong></span></li>\n<li><span><strong>Central</strong> <strong>Nervous</strong> system - <strong>anencephaly</strong>, microcephaly, <strong>neural</strong> <strong>tube</strong> <strong>defects</strong>, caudal regression syndrome, and <strong>sacral</strong> <strong>agenesis</strong></span></li>\n</ol>\n<p><span>Other options:</span></p>\n<p><span>Option B: <strong>Congenital</strong> <strong>rubella</strong> <strong>syndrome</strong> presents with the classical <strong>triad</strong> of <strong>deafness</strong>, <strong>cataract</strong>, and <strong>congenital</strong> <strong>heart</strong> <strong>disease </strong>(the most common being - patent ductus arteriosus). Eye findings also include salt and pepper retinopathy as shown below.</span></p>\n<p><span>Option C: <strong>Congenital</strong> <strong>hypothyroidism</strong> is the most common <strong>preventable</strong> cause of <strong>mental</strong> <strong>retardation</strong> and presents as <strong>6 P's</strong> - pot-bellied, pale, puffy-faced child with protruding umbilicus, protuberant tongue, and poor brain development</span></p>\n<p><span>Option D: <strong>Gestational</strong> <strong>hypertension</strong> primarily occurs due to the failure of the invasion of extravillous trophoblasts into the spiral artery. It is defined as a rise in blood pressure <strong>&gt;140/90</strong> mmHg <strong>after 20</strong> <strong>weeks</strong> of pregnancy (without proteinuria). It usually leads to intrauterine growth restriction (<strong>IUGR</strong>) and <strong>fetal</strong> <strong>death</strong>.</span></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0007621cfa5a451a8ebddfb071ffb3b0.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7575",
      "difficulty": "easy"
    },
    {
      "text": "The hormone acting on post ovulatory endometrium is :",
      "choices": [
        {
          "id": 1,
          "text": "Luteinizing hormone"
        },
        {
          "id": 2,
          "text": "Follicular stimulating hormone"
        },
        {
          "id": 3,
          "text": "Progesterone"
        },
        {
          "id": 4,
          "text": "Oestrogen"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The hormone acting on the <strong>post-ovulatory endometrium</strong> is<strong> progesterone. </strong></p>\n<p><strong>Endometrium</strong> undergoes changes (endometrial cycle) during the <strong>menstrual</strong> <strong>cycle</strong> due to the action of various hormones. The <strong>basal</strong> <strong>zone</strong> (lower 1/3rd of the endometrium in contact with the myometrium) is <strong>uninfluenced</strong> by <strong>hormones</strong> and <strong>shows</strong> <strong>no</strong> <strong>change</strong> during the cycle. The rest (<strong>functional</strong> <strong>zone</strong>) shows the following changes:</p>\n<ol>\n<li><strong>Regenerative</strong> <strong>phase</strong> (first 2 to 3 days)- the regeneration of glands and the stromal cells from the basal zone. Endometrial thickness is about <strong>2mm</strong>.</li>\n<li><strong>Proliferative</strong> <strong>phase</strong> (5 or 6th day to 14th day) - estrogen <strong>(option D)</strong> causes the glands to become more tubular and perpendicular to the surface and increases the thickness to <strong>10-12mm</strong> on the 14th day (at the time of ovulation)</li>\n<li><strong>Secretory</strong> <strong>phase</strong>(15th day till menstrual bleeding) - post ovulation, estrogen-primed endometrium is acted by<strong> progesterone&nbsp;</strong>(from corpus lutetium)&nbsp;and causes increased blood flow (<strong>spiraling</strong> of arteries) and increases tortuosity of glands (<strong>saw-toothed/cork</strong>-<strong>screwed</strong> <strong>glands</strong>). The thickness of the endometrium is <strong>maximum</strong> (<strong>12</strong><strong>mm</strong>) in this phase.</li>\n<li><strong>Menstruation</strong> (last 4 or 5 days) - estrogen and progesterone are withdrawn due to the regression of corpus luteum (lack of fertilization). This results in the <strong>shedding</strong> of the <strong>functional</strong> <strong>zone</strong> (menstrual bleeding).</li>\n</ol><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/534f093039bf4b6299cb1139aebcb1cbx600x655.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: The luteinizing hormone (<strong>LH</strong>) is secreted by the <strong>anterior</strong> <strong>pituitary</strong> and is crucial for <strong>ovulation</strong> to occur on the <strong>14th</strong> <strong>day</strong> of the menstrual cycle.</p>\n<p>Option B: Follicular stimulating hormone (<strong>FSH</strong>) is secreted by the <strong>anterior</strong> <strong>pituitary</strong>. The ovarian follicle with the most sensitivity to FSH becomes the <strong>dominant</strong> <strong>follicle</strong> for the current cycle and the rest undergo autolysis.</p><hr><h3>Related Pearl: Hormonal Regulation of Menstrual Cycle</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bbc6b519c9284220814b3e53c4f33f7ex1280x2327.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6e2111e3c6a3479d92653c803dfb5d4e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7574",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is an absolute contraindication to OCP use?",
      "choices": [
        {
          "id": 1,
          "text": "Chronic renal disease"
        },
        {
          "id": 2,
          "text": "Thromboembolism"
        },
        {
          "id": 3,
          "text": "History of amenorrhea"
        },
        {
          "id": 4,
          "text": "Diabetes mellitus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Thromboembolism</strong> is an absolute contraindication to OCP use.</p>\n<p><strong>Oral contraceptives (OCP)</strong> are preparations of<strong> estrogen </strong>or <strong>progesterone</strong> or a <strong>combination of both</strong>. <strong>Estrogen</strong> in OCPs <strong>suppresses</strong> gonadotropin-releasing hormone <strong>(GnRH)</strong> and follicle-stimulating hormone <strong>(FSH)</strong> whereas <strong>progesterone</strong> <strong>suppresses</strong> luteinizing hormone <strong>(LH)</strong>, thereby <strong>inhibiting</strong> <strong>ovulation</strong>.</p>\n<p>Though OCPs are generally used to prevent pregnancy, they are also indicated for the treatment of dysmenorrhoea, endometriosis, uterine fibroid, and dysfunctional uterine bleeding (DUB)</p>\n<p><strong>Contraindications</strong> of OCPs:</p>\n<ul>\n<li><strong>Absolute </strong>contraindications <strong>(WHO category 4)</strong>-\n<ul>\n<li><strong>History of thromboembolism- DVT, stroke</strong></li>\n<li>Heart diseases - Valular or ischemic</li>\n<li>Severe hypertension</li>\n<li>Liver diseases like hepatic adenoma, and hepatic carcinoma</li>\n<li><strong>Breastfeeding</strong></li>\n<li><strong>During pregnancy</strong></li>\n<li>Estrogen dependant neoplasms like - <strong>breast cancer</strong></li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Relative </strong>contraindications<strong> -</strong>&nbsp;\n<ul>\n<li>\n<div class=\"page\" title=\"Page 146\"><strong>WHO category-2</strong> (benefits outweigh the risks) - cancer cervix, cervical intraepithelial neoplasia (CIN), and in patients with sickle cell anemia, disease of the gallbladder, or diabetes mellitus <strong>(option D)</strong>.</div>\n</li>\n<li><strong>WHO category-3</strong>(risks outweigh benefits) - patients with benign liver tumors, unexplained vaginal bleeding, or history of smoking &gt;20 cigarettes/day.</li>\n</ul>\n</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Minipills</strong> (progestin-only pills) could be used safely in renal disease as they<strong> reduced clotting risks</strong> and is <strong>not an absolute contraindication.</strong></p>\n<p>Option C: A history of amenorrhea is investigated based on the algorithm for <strong>primary</strong> or <strong>secondary</strong> <strong>amenorrhoea</strong>. <strong>OCPs</strong> are used to <strong>regularise</strong> <strong>menstruation</strong> in polycystic ovarian syndrome <strong>(PCOD)</strong> which is a cause of secondary amenorrhoea.</p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7480",
      "difficulty": "easy"
    },
    {
      "text": "What is the chromosome number of a partial hydatidiform mole?",
      "choices": [
        {
          "id": 1,
          "text": "46 XX"
        },
        {
          "id": 2,
          "text": "45 XY"
        },
        {
          "id": 3,
          "text": "69 XY"
        },
        {
          "id": 4,
          "text": "69 XXY"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Partial</strong> hydatidiform mole has a <strong>69XXY or 69XYY karyotype</strong>.</p>\n<p><strong>Hydatiform</strong> <strong>mole</strong> belongs to the <strong>benign</strong> group of gestational trophoblastic diseases <strong>(GTD)</strong>. It is an <strong>abnormality</strong> in <strong>chorionic</strong> <strong>villi</strong> making them <strong>partly</strong> <strong>proliferative</strong> and <strong>degenerative</strong>, thereby resulting in the formation of multiple small cysts. Based on the portion of the chorionic villi involved, they could be <strong>complete</strong> (<strong>diffused</strong>) or <strong>partial (focal)</strong></p><hr><h3>Related Pearl: Complete vs. Partial Mole</h3><p>Hydatidiform mole is a <strong>benign</strong> abnormal condition of the placenta characterized by partial degenerative or proliferative changes of the <strong>chorionic villi</strong>. Though benign, it has malignant potential. It is commonly seen in pregnancies of extreme reproductive age groups - <strong>teenage</strong> and women <strong>above 35 years</strong> of age. A previous <strong>history of molar pregnancy</strong> is also a strong risk factor for recurrence of this condition.</p>\n<p>Molar pregnancy is of 2 types - complete mole and partial mole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Partial mole</strong></td>\n<td><strong>Complete mole</strong></td>\n</tr>\n<tr>\n<td><strong>Karyotype</strong></td>\n<td>69 XYY or 69 XXY</td>\n<td>46 XX or 46 XY</td>\n</tr>\n<tr>\n<td><strong>Diagnosis</strong></td>\n<td>Missed abortion</td>\n<td>Molar gestation</td>\n</tr>\n<tr>\n<td><strong>Uterus size</strong></td>\n<td>Small for date</td>\n<td>Large for date</td>\n</tr>\n<tr>\n<td><strong>Theca-lutein cysts</strong></td>\n<td>Rare</td>\n<td>25&ndash;30% of cases</td>\n</tr>\n<tr>\n<td><strong>Initial hCG levels</strong></td>\n<td>&lt;1 lakh mIU/ml</td>\n<td>&gt;1 lakh mIU/ml</td>\n</tr>\n<tr>\n<td><strong>Medical complications</strong></td>\n<td>Rare</td>\n<td>Uncommon</td>\n</tr>\n<tr>\n<td><strong>Rate of subsequent GTN</strong></td>\n<td>1&ndash;5%</td>\n<td>15&ndash;20%</td>\n</tr>\n<tr>\n<td><strong>Embryo-fetus</strong></td>\n<td>&nbsp;Often present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Amnion, fetal erythrocytes</strong></td>\n<td>Often present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Villous edema</strong></td>\n<td>&nbsp;Focal</td>\n<td>Widespread</td>\n</tr>\n<tr>\n<td><strong>Trophoblastic proliferation</strong></td>\n<td>Focal, slight to moderate</td>\n<td>Slight to severe</td>\n</tr>\n<tr>\n<td><strong>Trophoblast atypia</strong></td>\n<td>Mild</td>\n<td>Marked</td>\n</tr>\n<tr>\n<td><strong>p57KIP2 immunostaining</strong></td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/abb92edd8fe94b1997c1f9c5bf1a559ex1280x2039.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7485",
      "difficulty": "easy"
    },
    {
      "text": "A 55-year-old lady presents with third degree uterine prolapse. Which of the following is the best management for her?",
      "choices": [
        {
          "id": 1,
          "text": "Fothergill repair"
        },
        {
          "id": 2,
          "text": "Sling operation"
        },
        {
          "id": 3,
          "text": "Vaginal hysterectomy with pelvic floor repair"
        },
        {
          "id": 4,
          "text": "Shirodkar procedure"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the clinal scenario of a <strong>55-year-old</strong> woman with <strong>third-degree uterine prolapse</strong>, the ideal management is <strong>vaginal hysterectomy with pelvic floor repair</strong>.&nbsp;</p>\n<p>Uterine prolapse is the descent of the uterus from its normal position which usually occurs due to laxity of ligaments that offer support, seen often due to childbirth, aging, or trauma. The uterine descent is clinically categorized into:</p>\n<ul>\n<li><strong>First</strong> degree:&nbsp; the <strong>external</strong> <strong>os</strong> remains <strong>above</strong> the vaginal <strong>introitus</strong></li>\n<li><strong>Second</strong> degree: The <strong>external</strong> <strong>os</strong> protrudes <strong>below</strong> the vaginal <strong>introitus</strong> but the uterine body remains inside the vagina&nbsp;</li>\n<li>Third degree (Syn: <strong>Complete</strong> <strong>prolapse</strong>): The <strong>uterine,</strong> <strong>cervix,</strong> <strong>body,</strong> and <strong>fundus</strong> descend to lie <strong>outside</strong> the <strong>introitus</strong></li>\n<li><strong>Procidentia</strong> involves prolapse of the uterus with the <strong>entire</strong> <strong>vagina everted</strong>.</li>\n</ul>\n<p>The patient usually presents with a sense of heaviness in the pelvic region with lower back discomfort. Based on the structures involved the patient can additionally have urinary symptoms (like incontinence and urgency), bowel disturbances (constipation and tenesmus), or sexual discomfort during intercourse.</p>\n<p><strong>Symptomatic</strong> uterine prolapse is managed <strong>surgically</strong> with different procedures based on the profile of the patient. <strong>Conservative</strong> management is done for <strong>old asymptomatic</strong> <strong>women</strong> with <strong>mild</strong> <strong>degree</strong> <strong>prolapse</strong>.&nbsp;</p>\n<p>A <strong>vaginal</strong> <strong>hysterectomy</strong> is recommended for patients who satisfy the following criteria:</p>\n<ul>\n<li><strong>&gt;40</strong> years of age&nbsp;</li>\n<li>Have <strong>completed</strong> their <strong>families</strong></li>\n<li>Do <strong>not</strong> wish to <strong>preserve</strong> menstrual and <strong>child-bearing</strong> function</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Fothergill</strong> <strong>repair</strong> or <strong>Manchester</strong> <strong>operation</strong> is a procedure done to <strong>preserve</strong> the <strong>reproductive</strong> <strong>function</strong> and vaginal prolapse with supravaginal cervix elongation. It initially involves preliminary curettage with low amputation of the cervix. After Mackenrodt's ligament is plicated,&nbsp; anterior colporrhaphy and colpoperineorrhaphy are performed.</p>\n<p>Option B: <strong>Sling</strong> <strong>operation</strong> (Purandare's operation) is indicated in <strong>congenital</strong> or <strong>nulliparous</strong> <strong>prolapse</strong> without cystocele. The procedure involves the extraperitoneal passage of rectus sheath strips joined to the anterior surface of the cervix by silk sutures.</p>\n<p>Option D: <strong>Shirodkar</strong> <strong>procedure</strong> is a type of <strong>abdominal</strong> <strong>sling</strong> <strong>surgery</strong> done in young women to <strong>retain</strong> <strong>menstrual</strong> and <strong>reproductive</strong> function. It involves using a sling to <strong>fix</strong> the <strong>cervix</strong> to the <strong>lumbosacral</strong> <strong>fascia</strong>.&nbsp;</p><hr><h3>Related Pearl: Management of Uterine prolapse</h3><table>\n<tbody>\n<tr>\n<td><strong>Category</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td>Nulliparous or congenital prolapse&nbsp;</td>\n<td>\n<p>Abdominal sling operations:</p>\n<div class=\"page\" title=\"Page 374\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Abdominal wall cervicopexy</li>\n<li>Shirodkar&rsquo;s abdominal sling operation</li>\n<li>Khanna&rsquo;s abdominal sling operation</li>\n</ul>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Pregnancy and postnatal period</td>\n<td>\n<ul>\n<li>Ring pessary (up to 16 weeks period of gestation)</li>\n<li>Pelvic floor exercises</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&lt;40 years&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n<td>\n<ul>\n<li>Fothergill's repair (Manchester operation)</li>\n<li>Shirodkar's procedure</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&gt;40 years - with completed family&nbsp;</td>\n<td>Vaginal hysterectomy and pelvic floor repair&nbsp;</td>\n</tr>\n<tr>\n<td>&gt;60 years - unfit for surgery&nbsp;</td>\n<td>\n<ul>\n<li>Le Fort's repair</li>\n<li>Colpocleisis</li>\n</ul>\n<p>These are done if the patient doesn't want to retain sexual function&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2982",
      "difficulty": "easy"
    },
    {
      "text": "What is the dose of Ulipristal used in emergency contraception?",
      "choices": [
        {
          "id": 1,
          "text": "30 mg"
        },
        {
          "id": 2,
          "text": "300 mg"
        },
        {
          "id": 3,
          "text": "60 mg"
        },
        {
          "id": 4,
          "text": "600 mg"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The dose of <strong>Ulipristal</strong> in emergency&nbsp; contraception is <strong>30 mg to be taken within 72 hrs (upto 120hrs).</strong></p>\n<p><strong>Methods of Emergency contraception</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Dose</strong></td>\n</tr>\n<tr>\n<td>Levonorgestrel</td>\n<td>0.75mg stat and after 12 hours</td>\n</tr>\n<tr>\n<td>Ethinyl estradiol 50 &mu;g + Norgestrel 0.25 mg</td>\n<td>2 tab stat and 2 tab after 12 hours</td>\n</tr>\n<tr>\n<td>Conjugated estrogen</td>\n<td>15 mg BD x 5 days</td>\n</tr>\n<tr>\n<td>Ethinyl Estradiol</td>\n<td>2.5 mg BD X 5 days</td>\n</tr>\n<tr>\n<td>Copper IUDs</td>\n<td>Insertion within 5-7 days after accidental unprotected exposure.Not suitable for rape victims</td>\n</tr>\n<tr>\n<td>Centchroman</td>\n<td>2 tablets(60 mg) to be taken twice at an interval&nbsp; of 12 hours within 24 hours of intercourse.</td>\n</tr>\n<tr>\n<td>Ulipristal</td>\n<td>30 mg within 72 hours</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7503",
      "difficulty": "medium"
    },
    {
      "text": "What is the ideal time for nuchal translucency evaluation?",
      "choices": [
        {
          "id": 1,
          "text": "6-8 weeks"
        },
        {
          "id": 2,
          "text": "11-14 weeks"
        },
        {
          "id": 3,
          "text": "14-16 weeks"
        },
        {
          "id": 4,
          "text": "16-20 weeks"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"page\" title=\"Page 215\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Nuchal translucency</strong> evaluation, a component of <strong>first-trimester</strong> aneuploidy screening, is done between <strong>11-14 weeks.</strong></p>\n<div class=\"page\" title=\"Page 215\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>It represents the maximum thickness of the subcutaneous translucent area between the skin and soft tissue, overlying the fetal spine, at the back of the neck. When the nuchal translucency is <strong>increased</strong>, the <strong>risk of fetal aneuploidy</strong> and structural anomalies such as&nbsp;heart defects is significantly <strong>elevated</strong>.</p>\n<div class=\"page\" title=\"Page 215\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>First trimester aneuploidy screening</strong>&nbsp;combines two maternal serum analytes and a sonographic measurement:</p>\n<ol>\n<li>Human chorionic gonadotropin&nbsp;<strong>(hCG)</strong></li>\n<li>Pregnancy-associated plasma protein A (<strong>PAPP-A</strong>)</li>\n<li>Nuchal translucency (<strong>NT</strong>)</li>\n</ol>\n<p>It is performed between&nbsp;<strong>11 and 14 weeks&nbsp;</strong>of&nbsp;gestation.&nbsp;In cases of fetal Down syndrome, the first-trimester serum-free&nbsp;<strong>&beta;-hCG&nbsp;</strong>level is<strong>&nbsp;higher&nbsp;</strong>and the&nbsp;<strong>PAPP-A&nbsp;</strong>level is<strong>&nbsp;lower</strong>.&nbsp;With trisomy 18 and trisomy 13, levels of both analytes are lower.</p>\n<p>Note: <strong>Nuchal fold</strong>&nbsp;is a normal fold of skin seen at the back of the fetal neck during the <strong>second trimester</strong> of pregnancy. <strong>Increased</strong> nuchal fold <strong>thickness</strong> is associated with <strong>fetal aneuploidy.</strong></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/80eecda627d649f88eabb4729ca2c85ax796x599.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Fetal Monitoring using Ultrasound</h3><ul class=\"ul1\">\n<li class=\"li1\">The first definitive USG finding to suggest pregnancy is the visualization of the gestational sac.</li>\n<li class=\"li1\">The first sign of intrauterine pregnancy is the presence of yolk sac within the gestational sac.</li>\n<li class=\"li1\">Best time to assess gestational age by USG is 9-12 weeks(by CRL)</li>\n<li class=\"li1\">CRL(mm)+42 = Days of pregnancy</li>\n<li class=\"li1\">CRL(cm)+6.5 = Gestational age in weeks.</li>\n<li class=\"li1\">The best indicator of fetal growth is the abdominal circumference.&nbsp;Abdominal circumference is the transverse measurement at the level of the stomach with the confluence of the umbilical vein and right portal vein.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9945",
      "difficulty": "easy"
    },
    {
      "text": "Magnesium sulphate has no role in:",
      "choices": [
        {
          "id": 1,
          "text": "Prevention of seizures in severe pre-eclampsia"
        },
        {
          "id": 2,
          "text": "Prevention of recurrent seizures in eclampsia"
        },
        {
          "id": 3,
          "text": "Prevention of RDS in premature baby"
        },
        {
          "id": 4,
          "text": "Reducing contractility of uterus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Magnesium sulfate has <strong>no role </strong>in the prevention of respiratory distress syndrome (RDS) in a premature baby, where there is a deficit of surfactant (which results in alveolar collapse).</p>\n<p><strong>Magnesium</strong> in the MgSO<sub>4</sub>&nbsp;competes with <strong>calcium</strong> on <strong>voltage-gated</strong> <strong>calcium</strong> channels, thereby altering its uptake and release. Functions of MgSO<sub>4</sub>&nbsp;include :</p>\n<ul>\n<li><strong>Membrane</strong> <strong>protector</strong> and neuro stabilizer. It is used in the <strong>prevention</strong> of <strong>cerebral</strong> <strong>palsy</strong> in very low birth weight neonates.</li>\n<li>Reduction of <strong>motor</strong> <strong>endplate </strong>sensitivity to <strong>acetylcholine</strong>, and thus is used as an adjunct in the <strong>management</strong> of <strong>acute</strong> <strong>severe</strong> <strong>asthma</strong> in children and adults</li>\n<li>Blocking of <strong>neuronal</strong> <strong>calcium</strong> <strong>influx</strong>, and is thus used in the <strong>conservative</strong> <strong>management</strong> of pre-term labor (<strong>tocolytic</strong>, option D)</li>\n<li>Inducing <strong>cerebral</strong> <strong>vasodilatation</strong>, <strong>dilating</strong> the <strong>uterine</strong> <strong>arteries</strong>, increasing the production of endothelial prostacyclin, and <strong>inhibiting</strong> <strong>platelet</strong> <strong>activation</strong>. Hence it is used in the management of <strong>pre-eclampsia </strong>(option A) and to prevent progression to <strong>eclampsia</strong> (option A).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7495",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is seen in the vertex presentation with complete flexion attitude of head?",
      "choices": [
        {
          "id": 1,
          "text": "Suboccipito-bregmatic diameter"
        },
        {
          "id": 2,
          "text": "Suboccipito-frontal diameter"
        },
        {
          "id": 3,
          "text": "Occipito-frontal diameter"
        },
        {
          "id": 4,
          "text": "Occipito-posterior position"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Suboccipito-bregmatic diameter</strong> is seen in <strong>vertex</strong> presentation with a <strong>complete flexion</strong> attitude of the head. &nbsp;</p>\n<p>Diameters of the fetal skull:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Diameters</strong></td>\n<td><strong>Attitude of the head</strong></td>\n</tr>\n<tr>\n<td>Suboccipitobregmatic</td>\n<td>Complete flexion</td>\n</tr>\n<tr>\n<td>Suboccipito-frontal</td>\n<td>Incomplete flexion</td>\n</tr>\n<tr>\n<td>Occipitofrontal</td>\n<td>Marked deflexion</td>\n</tr>\n<tr>\n<td>Mento-vertical</td>\n<td>Partial extension</td>\n</tr>\n<tr>\n<td>Submentovertical</td>\n<td>Incomplete extension</td>\n</tr>\n<tr>\n<td>Submentobregmatic</td>\n<td>Complete extension</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Fetal Skull Dimensions</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/85a3054e190643c78183fa3e3093f9f1x1280x3161.JPEG\" alt=\"Pearl Image\"><p>Note:&nbsp;</p>\n<p>Shortest diameters of fetal skull:<strong>&nbsp;</strong>Bimastoid -&nbsp;<strong>7.5 cm </strong>(doesn't engage)&nbsp;&lt;<strong>&nbsp;</strong>Bitemporal -&nbsp;<strong>8 cm</strong></p>\n<p>Longest diameter of fetal skull:<strong>&nbsp;</strong>Mentovertical <strong>14 cm</strong>&nbsp;&gt;&nbsp;Submentovertical / occipitofrontal -&nbsp;<strong>11.5cm</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7496",
      "difficulty": "easy"
    },
    {
      "text": "A pregnant lady with a ​history of recurrent abortions is now diagnosed to have antiphospholipid syndrome. What would be the best mode of treatment for her?",
      "choices": [
        {
          "id": 1,
          "text": "Aspirin only"
        },
        {
          "id": 2,
          "text": "Aspirin+heparin"
        },
        {
          "id": 3,
          "text": "Aspirin+heparin+steroids"
        },
        {
          "id": 4,
          "text": "Aspirin+steroids"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The best mode of treatment for a pregnant woman with <strong>antiphospholipid s</strong><strong>yndrome</strong>(APS) is <strong>aspirin</strong> and <strong>heparin.</strong></p>\n<p><strong>APS&nbsp;</strong>is a prothrombotic disorder (<strong>autoantibody-mediated thrombophilia</strong>) affecting both arterial and venous systems.</p>\n<p>Patients present with <strong>recurrent</strong> <strong>pregnancy loss</strong> due to thrombosis of <strong>uteroplacental</strong> <strong>vessels</strong>, poor placental perfusion, and prevention of normal decidual changes after zygote implantation. They may also present with preterm delivery, pre-eclampsia, intrauterine growth restriction (IUGR), and fetal death.</p>\n<p>Criteria for APS include:</p>\n<ol>\n<li>at least one otherwise unexplained fetal death at or beyond 10 weeks;</li>\n<li>at least one preterm birth before 34 weeks gestation because of eclampsia, severe preeclampsia, placental insufficiency; or</li>\n<li>at least three unexplained consecutive spontaneous abortions before 10 weeks.&nbsp;</li>\n</ol>\n<p><strong>Aspirin</strong> (60-80mg daily)<strong> with</strong> <strong>heparin</strong> (5000-10,000 U subcutaneously every 12h) is the<strong> most effective therapy </strong>for APS. Treating APS with only aspirin <strong>(option A)</strong> is not recommended as heparin is crucial in preventing thrombus formation at the decidual-thrombotic interface, Corticosteroids <strong>(option C, D)</strong> should <strong>not</strong> be used in <strong>primary</strong> <strong>APS</strong> (without an associated connective tissue disorder) but are indicated in patients with pre-existing systemic lupus erythematosus (SLE) and APS (secondary APS).&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7491",
      "difficulty": "easy"
    },
    {
      "text": "A 22-year-old pregnant lady presented with a fever and was started on antibiotics. The fever did not subside. On further investigation, she was diagnosed to have septic pelvic thrombophlebitis. Which among the following is the next course of treatment for her?",
      "choices": [
        {
          "id": 1,
          "text": "Stop antibiotics and start heparin"
        },
        {
          "id": 2,
          "text": "Antibiotics+Heparin"
        },
        {
          "id": 3,
          "text": "Surgical embolectomy"
        },
        {
          "id": 4,
          "text": "Hysterectomy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Antibiotics plus heparin</strong> is the next course of treatment for <strong>septic pelvic thrombophlebitis</strong>.</p>\n<p>Septic pelvic thrombophlebitis <strong>(SPT)</strong> refers to the <strong>pelvic infection</strong> with <strong>thrombosis of one/both ovarian veins</strong>. The pathogenesis of this disease is due to the <strong>spreading uterine infection</strong> (secondary to trauma of delivery or surgery) combined with the <strong>hypercoagulable state of the pregnancy</strong> (thrombus formation).&nbsp;</p>\n<p>The patients usually present with <strong>constant lower abdominal pain</strong> and occasionally with a palpable tender sausage-shaped mass (most diagnostic finding, but rare).</p>\n<p>SPT is usually <strong>suspected</strong> when the <strong>fever fails to respond to antibiotic therapy</strong>. It can be <strong>confirmed</strong> by computed tomography (<strong>CT</strong>) or magnetic resonance imaging (<strong>MRI</strong>) of the abdomen and pelvis. Patients are treated with a <strong>combination</strong> of <strong>heparin</strong> and <strong>broad-spectrum antibiotics</strong>. Anticoagulation is done to <strong>prevent further thrombosis</strong> and <strong>reduce</strong> the <strong>spread of septic emboli</strong>.</p>\n<p>Note: The use of anticoagulation is controversial as not all clinicians favor it. A small randomized study did not demonstrate a benefit, but the majority accept short-term anticoagulation as a part of the treatment regimen.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7492",
      "difficulty": "easy"
    },
    {
      "text": "What is the treatment of choice for a woman with atrophic vaginitis with complaints of itching?",
      "choices": [
        {
          "id": 1,
          "text": "Steroids"
        },
        {
          "id": 2,
          "text": "Topical estrogen"
        },
        {
          "id": 3,
          "text": "Antihistamines only"
        },
        {
          "id": 4,
          "text": "None of the above"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Atrophic vaginitis is treated with<strong> topical estrogen </strong>vaginal cream.</p>\n<p><strong>Atrophic vaginitis</strong> (senile vaginitis) is seen in <strong>postmenopausal women</strong> due to the<strong> thinning of vaginal mucosa </strong>(lack of estrogen). They present as discomfort (<strong>itching</strong>) and <strong>dryness</strong> in the vulva with <strong>dyspareunia</strong>. Occasionally, they may also complain of yellowish or blood-stained vaginal discharge.</p>\n<p>The possibility of a <strong>coexisting</strong> <strong>carcinoma</strong> of the body or the cervix has to be <strong>excluded</strong> <strong>before</strong> <strong>treating</strong> it with estrogen supplements. Though <strong>topical</strong> <strong>application</strong> is the <strong>initial</strong> <strong>treatment</strong>, systemic estrogens (hormone replacement therapy) can be considered based on the patient's profile and the severity of the symptoms.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Steroids</strong> are not indicated in the management of atrophic vaginitis as the inflammation is due to a <strong>lack of estrogen</strong>. Furthermore, they may predispose the patient to vaginal infections.</p>\n<p>Option C: <strong>Antihistamines</strong> antagonize histamine receptors and prevent the allergic response. Since atrophic vaginitis is <strong>not an allergy response</strong>, they are not indicated in the treatment.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7524",
      "difficulty": "easy"
    }
  ]
}